Ziegelhöffer A, Ravingerová T, Styk J, Seboková J, Waczulíková I, Breier A, Dzurba A, Volkovová K, Cársky J, Turecký L
Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Mol Cell Biochem. 1997 Nov;176(1-2):191-8.
In diabetes the hearts exhibit impaired membrane functions, but also increased tolerance to Ca2+ (iCaT) However, neither the true meaning nor the molecular mechanisms of these changes are fully understood. The present study is devoted to elucidation of molecular alterations, particularly those induced by non-enzymatic glycation of proteins, that may be responsible for iCaT of the rat hearts in the stage of fully developed, but still compensated diabetic cardiomyopathy (DH). Insulin-dependent diabetes (DIA) was induced by a single i.v. dose of streptozotocin (45 mg.kg-1). Beginning with the subsequent day, animals obtained 6 U insulin daily. Glucose, triglycerides, cholesterol and glycohemoglobin were investigated in blood. ATPase activities, the kinetics of activation of (Na,K)-ATPase by Na+ and K+, further the fluorescence anisotropy of diphenyl-hexatriene as well as the order parameters of membranes in isolated heart sarcolemma (SL) were also investigated. In addition, the degree of glycation and glycation-related potency for radical generation in SL proteins were determined by investigating their fructosamine content. In order to study calcium tolerance of DH in a 'transparent' model, hearts were subjected to calcium paradox (Ca-Pa, 3 min of Ca2+ depletion; 10 min of Ca2+ repletion). In this model of Ca(2+)-overload, Ca2+ ions enter the cardiac cells in a way that is not mediated by receptors. Results revealed that more than 83% of the isolated perfused DH recovered, while the non-DIA control hearts all failed after Ca-Pa. DH exhibited well preserved SL ATPase activities and kinetics of (Na,K)-ATPase activation by Na+, even after the Ca-Pa. This was considered as a reason for their iCaT. Pretreatment and administration of resorcylidene aminoguanidine (RAG 4 or 8 mg.kg-1) during the disease prevented partially the pathobiochemical effects of DIA-induced glycation of SL proteins. DIA-induced perturbations in anisotropy and order parameters of SL were completely prevented by administration of RAG (4 mg.kg-1). Although, the latter treatment exerted little influence on the (Na,K)-ATPase activity, it decreased the calcium tolerance of the DH. Results are supporting our hypothesis that the glycation-induced enhancement in free radical formation and protein crosslinking in SL may participate in adaptive mechanisms that may be also considered as 'positive' and are responsible for iCaT of the DH.
在糖尿病状态下,心脏表现出膜功能受损,但同时对Ca2+的耐受性也增加(即iCaT)。然而,这些变化的真正意义和分子机制尚未完全明了。本研究致力于阐明分子改变,特别是由蛋白质非酶糖基化诱导的那些改变,这些改变可能是大鼠心脏在完全发展但仍处于代偿阶段的糖尿病性心肌病(DH)中iCaT的原因。通过静脉注射单次剂量的链脲佐菌素(45 mg·kg-1)诱导胰岛素依赖型糖尿病(DIA)。从第二天开始,动物每天注射6 U胰岛素。检测血液中的葡萄糖、甘油三酯、胆固醇和糖化血红蛋白。还研究了ATP酶活性、Na+和K+对(Na,K)-ATP酶的激活动力学、二苯基己三烯的荧光各向异性以及分离的心脏肌膜(SL)中膜的序参数。此外,通过检测SL蛋白中的果糖胺含量,确定SL蛋白的糖基化程度和与糖基化相关的自由基生成能力。为了在一个“透明”模型中研究DH的钙耐受性,对心脏进行钙反常处理(Ca-Pa,3分钟Ca2+耗竭;10分钟Ca2+再灌注)。在这个Ca(2+)过载模型中,Ca2+离子以一种不受受体介导的方式进入心肌细胞。结果显示,超过83%的分离灌注DH心脏恢复,而未患DIA的对照心脏在Ca-Pa处理后全部衰竭。即使在Ca-Pa处理后,DH心脏的SL ATP酶活性和Na+对(Na,K)-ATP酶的激活动力学仍保持良好。这被认为是它们具有iCaT的原因。在疾病期间预先给予并持续给予间二羟基苯叉基氨基胍(RAG 4或8 mg·kg-1)可部分预防DIA诱导的SL蛋白糖基化的病理生化效应。给予RAG(4 mg·kg-1)可完全预防DIA诱导的SL各向异性和序参数的扰动。尽管后一种处理对(Na,K)-ATP酶活性影响不大,但它降低了DH心脏的钙耐受性。结果支持了我们的假设,即糖基化诱导的SL中自由基形成增强和蛋白质交联可能参与了适应性机制,这些机制也可被视为“积极的”,并且是DH心脏iCaT的原因。